Table 3.
Correlation coefficients of total antioxidant capacity measures and uric acid concentration to physical activity and fitness characteristics in men with and without CHD.
| Variable | Group I (CHD patients) | Group II (without CHD) | ||||
|---|---|---|---|---|---|---|
| TAC-FRAS (mmol FeCl2·L−1) |
TAC-DPPH (% reduction) |
UA (mg·dL−1) |
TAC-FRAS (mmol FeCl2·L−1) |
TAC-DPPH (% reduction) |
UA (mg·dL−1) |
|
| Energy expenditure for LTPA (kcal·week−1) | −0.12 | −0.24 * | −0.04 | 0.004 | −0.03 | −0.13 |
| Energy expenditure for LTPA (kcal·week−1·kg−1) | −0.14 | −0.23 * | −0.04 | 0.03 | 0.004 | −0.16 |
| PWC85%HRmax (W) | −0.16 | −0.0008 | −0.14 | −0.06 | −0.02 | −0.01 |
| PWC85%HRmax/kg (W·kg−1) | −0.29 † | −0.07 | −0.26 * | −0.09 | 0.03 | −0.16 |
| UA (mg·dL−1) | 0.60 † | 0.37 † | — | 0.64 † | 0.30 † | — |
* P < 0.05, † P ≤ 0.01.
UA: uric acid, LTPA: leisure time physical activity, PWC: physical working capacity, HR: heart rate, TAC: total antioxidant capacity, FRAS: Ferric Reducing Ability of Serum, DPPH: 2.2-diphenyl-1-picryl-hydrazyl, and CHD: coronary heart disease.